A citation-based method for searching scientific literature

U Mrowietz, R B Warren, C L Leonardi, D Saure, H Petto, S Hartz, M Dossenbach, K Reich. J Eur Acad Dermatol Venereol 2021
Times Cited: 4







List of co-cited articles
29 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity





Indirect comparison of anti-interleukin 17 targeted biological treatments for moderate-to-severe psoriasis.
Rocío Díaz Acedo, Mercedes Galvan Banqueri, Esther Márquez Saavedra. J Clin Pharm Ther 2020
2
100

A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease Domains.
Tiago Torres, Anabela Barcelos, Paulo Filipe, João Eurico Fonseca. Front Med (Lausanne) 2021
5
50

Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis.
Richard B Warren, Melinda Gooderham, Russel Burge, Baojin Zhu, David Amato, Karen Huayu Liu, David Shrom, Jiaying Guo, Alan Brnabic, Andrew Blauvelt. J Am Acad Dermatol 2020
23
50

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Giao Do, Camille Hua, Canelle Mazaud, Catherine Droitcourt, Carolyn Hughes, John R Ingram, Luigi Naldi,[...]. Cochrane Database Syst Rev 2017
147
50


Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data.
Neil H Shear, Keith A Betts, Ahmed M Soliman, Avani Joshi, Yan Wang, Jing Zhao, Paolo Gisondi, Ranjeeta Sinvhal, April W Armstrong. J Am Acad Dermatol 2021
5
50



Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year.
Najeeda Yasmeen, Laura M Sawyer, Kinga Malottki, Lars-Åke Levin, Eydna Didriksen Apol, Gregor B Jemec. J Dermatolog Treat 2022
17
50


Comparative efficacy and safety of biologics in moderate to severe plaque psoriasis: a multiple-treatments meta-analysis.
Shanshan Xu, Xing Gao, Jixiang Deng, Jiajia Yang, Faming Pan. J Dtsch Dermatol Ges 2021
3
66

National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study.
Rosa Parisi, Ireny Y K Iskandar, Evangelos Kontopantelis, Matthias Augustin, Christopher E M Griffiths, Darren M Ashcroft. BMJ 2020
133
50

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses.
Richard B Warren, Kyoungah See, Russel Burge, Ying Zhang, Alan Brnabic, Gaia Gallo, Alyssa Garrelts, Alexander Egeberg. Dermatol Ther (Heidelb) 2020
18
50

A Systematic Literature Review and Bucher Indirect Comparison: Tildrakizumab versus Guselkumab.
Kristian Garn Du Jardin, Pepi Hurtado Lopez, Mette Lange, Rachael McCool, Silvia Maeso Naval, Sandra Quickert. J Health Econ Outcomes Res 2020
4
50

Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis.
April W Armstrong, Luis Puig, Avani Joshi, Martha Skup, David Williams, Junlong Li, Keith A Betts, Matthias Augustin. JAMA Dermatol 2020
68
50

Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis.
S K Mahil, M C Ezejimofor, L S Exton, L Manounah, A D Burden, L C Coates, M de Brito, A McGuire, R Murphy, C M Owen,[...]. Br J Dermatol 2020
22
50



Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis.
Yayoi Tada, Rei Watanabe, Hisashi Noma, Yasumasa Kanai, Takanobu Nomura, Kenji Kaneko. J Dermatol Sci 2020
12
50

Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
N Woolacott, N Hawkins, A Mason, A Kainth, Z Khadjesari, Y Bravo Vergel, K Misso, K Light, R Chalmers, M Sculpher,[...]. Health Technol Assess 2006
119
50

Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis.
Weiguang Xue, Paranjoy Saharia, Emma Gray, Shoghag Khoudigian-Sinani, Véronique Gaudet, Martin Barbeau, Kim Papp. J Cutan Med Surg 2020
5
50

Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis.
Kristian Reich, Rodney Sinclair, Graeme Roberts, Christopher E M Griffiths, Maggie Tabberer, Jonathan Barker. Curr Med Res Opin 2008
37
50

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Emilie Sbidian, Anna Chaimani, Sivem Afach, Liz Doney, Corinna Dressler, Camille Hua, Canelle Mazaud, Céline Phan, Carolyn Hughes, Dru Riddle,[...]. Cochrane Database Syst Rev 2020
73
50

Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review.
Andrew Blauvelt, Russel Burge, William Malatestinic, Alan Brnabic, Jiaying Guo, Manju Janardhanan, Baojin Zhu. J Manag Care Spec Pharm 2021
2
100

Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response.
L M Sawyer, L Cornic, L Å Levin, C Gibbons, A H Møller, G B Jemec. J Eur Acad Dermatol Venereol 2019
53
50


Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ.
M Masson Regnault, J Castañeda-Sanabria, M H T Diep Tran, M Beylot-Barry, H Bachelez, N Beneton, O Chosidow, A Dupuy, P Joly, D Jullien,[...]. J Eur Acad Dermatol Venereol 2020
21
25

Absolute and relative psoriasis area and severity index (PASI) treatment goals and their association with health-related quality of life.
Sascha Gerdes, Andreas Körber, Mona Biermann, Claudia Karnthaler, Maximilian Reinhardt. J Dermatolog Treat 2020
11
25

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: treatment and monitoring recommendations.
A Nast, C Smith, P I Spuls, G Avila Valle, Z Bata-Csörgö, H Boonen, E De Jong, I Garcia-Doval, P Gisondi, D Kaur-Knudsen,[...]. J Eur Acad Dermatol Venereol 2020
40
25

Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial.
Philip J Mease, Proton Rahman, Alice B Gottlieb, Alexa P Kollmeier, Elizabeth C Hsia, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Yanli Zhuang,[...]. Lancet 2020
88
25

Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial.
Atul Deodhar, Philip S Helliwell, Wolf-Henning Boehncke, Alexa P Kollmeier, Elizabeth C Hsia, Ramanand A Subramanian, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou,[...]. Lancet 2020
88
25

Comparison of two independent systematic reviews of trials of recombinant human bone morphogenetic protein-2 (rhBMP-2): the Yale Open Data Access Medtronic Project.
Jeffrey Low, Joseph S Ross, Jessica D Ritchie, Cary P Gross, Richard Lehman, Haiqun Lin, Rongwei Fu, Lesley A Stewart, Harlan M Krumholz. Syst Rev 2017
9
25


Evidence synthesis for decision making 1: introduction.
Sofia Dias, Nicky J Welton, Alex J Sutton, A E Ades. Med Decis Making 2013
106
25

Network Meta-analysis of Treatments for Chronic Plaque Psoriasis in Canada.
Aditya K Gupta, Deanne Daigle, Danika C A Lyons. J Cutan Med Surg 2014
10
25

Most randomized controlled trials for psoriasis used placebo comparators despite the availability of effective treatments.
Sivem Afach, Theodoros Evrenoglou, Nadia Oubaya, Laurence Le Cleach, Emilie Sbidian. J Clin Epidemiol 2021
1
100

Comparative efficacy and safety of thirteen biologic therapies for patients with moderate or severe psoriasis: A network meta-analysis.
Guomei Xu, Meng Xia, Chenjie Jiang, Ying Yu, Guomi Wang, Jiaojiao Yuan, Xingwu Duan. J Pharmacol Sci 2019
19
25


Cost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan.
Atsuyuki Igarashi, Hiroyo Kuwabara, Kyle Fahrbach, Brad Schenkel. J Dermatolog Treat 2013
17
25

Number needed to treat and costs per responder among biologic treatments for moderate-to-severe plaque psoriasis in Japan.
Shinichi Imafuku, Ataru Nakano, Hidetoshi Dakeshita, Junlong Li, Keith A Betts, Annie Guerin. J Dermatolog Treat 2018
9
25

The comparative efficacy of brodalumab in patients with moderate-to-severe psoriasis: a systematic literature review and network meta-analysis.
Laura Sawyer, Iain Fotheringham, Emily Wright, Najeeda Yasmeen, Carl Gibbons, Anders Holmen Møller. J Dermatolog Treat 2018
21
25

Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response.
Laura M Sawyer, Kinga Malottki, Celia Sabry-Grant, Najeeda Yasmeen, Emily Wright, Anne Sohrt, Emma Borg, Richard B Warren. PLoS One 2019
69
25

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
25

Biological treatments for moderate-to-severe psoriasis: indirect comparison.
M Galván-Banqueri, R Marín Gil, B Santos Ramos, F J Bautista Paloma. J Clin Pharm Ther 2013
31
25

Overlapping network meta-analyses on the same topic: survey of published studies.
F Naudet, E Schuit, J P A Ioannidis. Int J Epidemiol 2017
19
25

Evidence synthesis for decision making 7: a reviewer's checklist.
A E Ades, Deborah M Caldwell, Stefanie Reken, Nicky J Welton, Alex J Sutton, Sofia Dias. Med Decis Making 2013
48
25



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.